-
Something wrong with this record ?
Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a
Z. Tomášová, P. Hluštík, M. Král, P. Otruba, R. Herzig, A. Krobot, P. Kaňovský,
Language English Country United States
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Botulinum Toxins, Type A therapeutic use MeSH
- Stroke complications drug therapy physiopathology MeSH
- Evoked Potentials * MeSH
- Middle Aged MeSH
- Humans MeSH
- Neuromuscular Agents therapeutic use MeSH
- Arm MeSH
- Movement MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Sensorimotor Cortex drug effects physiopathology MeSH
- Muscle Spasticity drug therapy etiology physiopathology MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND AND PURPOSE: Botulinum toxin (BoNT) treatment relieves focal arm spasticity after stroke, likely acting at several hierarchical levels of the motor system. The central correlate of BoNT-induced spasticity relief may be detected using repeated functional MRI (fMRI) during motor task. METHODS: Five patients (4 males, 1 female, mean age 67 years) with hemiparesis and distal arm spasticity after chronic ischemic stroke were studied. FMRI was performed while moving the paretic hand in three sessions: before and 4 and 11 weeks after BoNT treatment. RESULTS: Arm spasticity significantly decreased following BoNT treatment across the group (mean modified Ashworth scale change .6). FMRI prior to BoNT treatment showed extensive bilateral active networks, whereas post-BoNT activation was limited to midline and contralateral sensorimotor cortices, and the third examination, when the toxin effect has worn off, again showed extensive activation similar to pre-BoNT examination. Post-BoNT session 2 compared to sessions 1 and 3 demonstrated a significantly less activation in contralateral frontoparietal areas including inferior frontal, postcentral, and middle frontal gyri as well as transient crossed cerebellar activation. CONCLUSION: Relief of post-stroke arm spasticity may be associated with changes at several hierarchical levels of the cortical sensorimotor system, including the prefrontal cortex.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15032123
- 003
- CZ-PrNML
- 005
- 20151013122811.0
- 007
- ta
- 008
- 151005s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1552-6569.2011.00682.x $2 doi
- 035 __
- $a (PubMed)22212022
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tomášová, Zuzana $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic.
- 245 10
- $a Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a / $c Z. Tomášová, P. Hluštík, M. Král, P. Otruba, R. Herzig, A. Krobot, P. Kaňovský,
- 520 9_
- $a BACKGROUND AND PURPOSE: Botulinum toxin (BoNT) treatment relieves focal arm spasticity after stroke, likely acting at several hierarchical levels of the motor system. The central correlate of BoNT-induced spasticity relief may be detected using repeated functional MRI (fMRI) during motor task. METHODS: Five patients (4 males, 1 female, mean age 67 years) with hemiparesis and distal arm spasticity after chronic ischemic stroke were studied. FMRI was performed while moving the paretic hand in three sessions: before and 4 and 11 weeks after BoNT treatment. RESULTS: Arm spasticity significantly decreased following BoNT treatment across the group (mean modified Ashworth scale change .6). FMRI prior to BoNT treatment showed extensive bilateral active networks, whereas post-BoNT activation was limited to midline and contralateral sensorimotor cortices, and the third examination, when the toxin effect has worn off, again showed extensive activation similar to pre-BoNT examination. Post-BoNT session 2 compared to sessions 1 and 3 demonstrated a significantly less activation in contralateral frontoparietal areas including inferior frontal, postcentral, and middle frontal gyri as well as transient crossed cerebellar activation. CONCLUSION: Relief of post-stroke arm spasticity may be associated with changes at several hierarchical levels of the cortical sensorimotor system, including the prefrontal cortex.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a paže $7 D001132
- 650 _2
- $a botulotoxiny typu A $x terapeutické užití $7 D019274
- 650 12
- $a evokované potenciály $7 D005071
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pohyb $7 D009068
- 650 _2
- $a svalová spasticita $x farmakoterapie $x etiologie $x patofyziologie $7 D009128
- 650 _2
- $a nervosvalové látky $x terapeutické užití $7 D009465
- 650 _2
- $a senzorimotorický kortex $x účinky léků $x patofyziologie $7 D066191
- 650 _2
- $a cévní mozková příhoda $x komplikace $x farmakoterapie $x patofyziologie $7 D020521
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hluštík, Petr
- 700 1_
- $a Král, Michal
- 700 1_
- $a Otruba, Pavel
- 700 1_
- $a Herzig, Roman
- 700 1_
- $a Krobot, Alois
- 700 1_
- $a Kaňovský, Petr
- 773 0_
- $w MED00002833 $t Journal of neuroimaging official journal of the American Society of Neuroimaging $x 1552-6569 $g Roč. 23, č. 3 (2013), s. 337-44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22212022 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151013123000 $b ABA008
- 999 __
- $a ok $b bmc $g 1092999 $s 915249
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 23 $c 3 $d 337-44 $e 20111230 $i 1552-6569 $m Journal of neuroimaging $n J Neuroimaging $x MED00002833
- LZP __
- $a Pubmed-20151005